2021 Annual Report cover

IBRI 2021 Annual Report “Accelerating Biomedical Innovation”

read the report

Schrödinger Suite of Tools

Accelerating innovation in drug discovery

Schrodinger logo

Schrödinger’s platform offers our scientists and members access to an extensive toolbox of sophisticated drug discovery technologies. This cutting-edge software is enabling our molecular innovation team to optimize molecular therapeutics and improve the effectiveness in targeting disease.

And, the computer simulations, property predictions and data management offered by Schrödinger, including the collaborative enterprise informatics platform LiveDesign, is transforming the way our scientists rapidly design and evaluate potential therapeutics.

Back to Scientific Resources.

Contacts

Jay McGill, PhD
Chief Operating Officer

Daniel Robertson, PhD
Vice President of Integrated Data Sciences